Transition Bio

Developer of a technology platform for the analysis of biomolecular condensate

placeCambridge, Massachusetts, United States calendar_todayFounded 2020 groups9 employees language transitionbio.com

Registered entities

Social engagement

Social engagement: 7.7K social following, 5 posts in the last 12 months — below the industry typical range.

Investor mix

5 investors on record; lead investors include Northpond Ventures, Lifeforce Capital.

Investor typeCountShare
Venture capital480%
Other / undisclosed120%

Recent activity

13 Apr 2026
Event
AACR26
10 Nov 2025
Partnership
Voyager Therapeutics, Inc.
23 Oct 2025
Event
Targets25
Coming soon